Antianginals

Known as: [CV250] ANTIANGINALS, Anti-anginal, Anti-anginal Agent 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
CONTEXT Despite the widespread use of percutaneous coronary intervention (PCI), the appropriateness of these procedures in… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Review
2009
Review
2009
Evolving knowledge regarding sex differences in coronary heart disease is emerging. Given the lower burden of obstructive… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2007
Highly Cited
2007
CONTEXT Ranolazine is a novel antianginal agent that reduces ischemia in patients with chronic angina but has not been studied in… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2002
Highly Cited
2002
BACKGROUND Current guidelines suggest that, for patients at moderate risk of death from unstable coronary-artery disease, either… (More)
  • figure 1
  • table 2
  • table 1
  • figure 3
  • figure 5
Is this relevant?
Highly Cited
1999
Highly Cited
1999
BACKGROUND The role of testosterone on the development of coronary artery disease in men is controversial. The evidence that men… (More)
  • table 1
  • table 3
  • table 2
  • table 4
  • figure 1
Is this relevant?
Highly Cited
1995
Highly Cited
1995
OBJECTIVES Our aim was to study the clinical characteristics and evolution of symptoms and left ventricular function in a… (More)
Is this relevant?
1991
1991
BACKGROUND Dipyridamole echocardiography test (DET: two-dimensional echocardiographic monitoring with dipyridamole infusion up to… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 4
Is this relevant?
1985
1985
We suspected that patients with severe chronic heart failure may show hemodynamic changes after cardiac catheterization in the… (More)
  • figure 1
  • table 1
Is this relevant?
1980
1980
In a double-blind clinical trial the antianginal effects of nifedipine (30 and 60 mg/day) and propranolol 240 and 480 mg/day) and… (More)
  • figure 2
  • figure 3
  • figure 1
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
1975
Highly Cited
1975
Effects on anginal symptoms of sudden withdrawal of large doses of propranolol or placebo were evaluated in 20 patients in a… (More)
Is this relevant?